Document is current
Any future updates will be listed below
-
Authors
Gleicher, Norbert
Mochizuki, Lyka
Barad, David H.
-
Funding
Funding for this research was provided by:
Center for Human Reproduction
Foundation for Reproductive Medicine
- License Information
-
More Information
Article History
Received: 10 February 2021
Accepted: 27 June 2021
First Online: 13 July 2021
Declarations
:
: N/A.
: N/A.
: N.G., and D.H.B. are listed as co-owners of several already awarded and still pending U.S. patents, some claiming benefits from androgen supplementation in women with low ovarian reserve, a topic addressed in this manuscript. N.G. is a shareholder in Fertility Nutraceuticals, LLC, which produces a DHEA product, and is owner of <i>The CHR</i>. N.G. and D.H.B. receive patent royalties from Fertility Nutraceuticals, LLC. N.G., and D.H.B also received research support, travel funding and lecture fees from various Pharma and medical device companies, none, in any way related to this manuscript.
